Loading clinical trials...
Loading clinical trials...
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Conditions
Interventions
Tacrolimus (CNI) Withdrawal
Standard Immunosuppressive Therapy
Locations
11
United States
University of California Los Angeles
Los Angeles, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Brigham & Women's Hospital
Boston, Massachusetts, United States
University of Michigan Hospital
Ann Arbor, Michigan, United States
Washington University
St Louis, Missouri, United States
Mount Sinai School of Medicine
New York, New York, United States
Start Date
November 1, 2010
Primary Completion Date
May 1, 2015
Completion Date
May 1, 2015
Last Updated
September 11, 2017
NCT05702398
NCT06806670
NCT05938712
NCT02555566
NCT04965935
NCT02424227
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions